152 Participants Needed

Rocuronium vs Succinylcholine for Anesthesia

LM
ET
Overseen ByEllie Tuchaai
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: The University of Texas Health Science Center, Houston
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the drugs Rocuronium and Succinylcholine for anesthesia?

Research suggests that Rocuronium can be an effective alternative to Succinylcholine for rapid-sequence induction of anesthesia, as it has a quick onset of action and lacks some of the adverse reactions associated with Succinylcholine. Additionally, Rocuronium, when used with Sugammadex, may offer benefits in time to tracheal intubation during cesarean delivery compared to Succinylcholine.12345

Is it safe to use Rocuronium or Succinylcholine for anesthesia?

Rocuronium is generally considered safe and has a good safety profile, while Succinylcholine can have several potential side effects, some of which may be serious. Rocuronium is often preferred due to its safety and similar rapid onset of action.23678

How do the drugs rocuronium and succinylcholine differ for anesthesia?

Rocuronium and succinylcholine are both used for rapid-sequence intubation during anesthesia, but rocuronium is a nondepolarizing muscle relaxant that avoids the adverse reactions associated with succinylcholine. Additionally, rocuronium can be reversed with sugammadex, offering a unique advantage in certain situations.23479

What is the purpose of this trial?

The purpose of this study is to assess and compare conditions for tracheal intubation obtained with modified time principal induction with 0.6 mg/kg rocuronium and 1 mg/kg succinylcholine. Specifically, the investigators will be evaluating ease of laryngoscopy, vocal cord view, vocal cord opening, and movement of limbs and coughing during tracheal intubation in order to assess intubation conditions, to compare efficiency and success rate of tracheal intubation between two induction agents and to determine the rate of patient awareness during induction and post-operative recall of paralysis.

Research Team

LM

Lauren M Nakazawa, MD

Principal Investigator

The University of Texas Health Science Center, Houston

Eligibility Criteria

This trial is for adults needing general anesthesia and intubation, with a BMI over 30 or a Mallampati score of III/IV. It's not for those allergic to certain anesthetics, pregnant women, people with severe health issues (ASA > III), renal failure with high potassium levels, respiratory disorders like COPD/asthma, untreated heart disease, history of malignant hyperthermia or neuromuscular diseases.

Inclusion Criteria

My BMI is over 30, or I have a high Mallampati score.
I will need general anesthesia and a breathing tube for my procedure.

Exclusion Criteria

The American Society of Anesthesiologists (ASA) physical status classification > III
Pregnant women
I have a neuromuscular disease or have suffered from burn injuries.
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Induction and Intubation

Participants undergo rapid sequence induction and tracheal intubation using either rocuronium or succinylcholine. Conditions such as ease of laryngoscopy, vocal cord view, and movement during intubation are assessed.

Less than 7 minutes
1 visit (in-person)

Post-operative Monitoring

Participants are monitored for post-operative recall of paralysis, injury associated with intubation, and overall satisfaction within 24 hours after surgery.

24 hours
1 visit (in-person)

Follow-up

Participants are monitored for any delayed adverse effects and overall satisfaction with the procedure.

1-2 weeks

Treatment Details

Interventions

  • Rocuronium
  • Succinylcholine
Trial Overview The study compares two drugs used during rapid anesthesia induction: rocuronium (0.6 mg/kg) and succinylcholine (1 mg/kg). It looks at how well they work for putting in a breathing tube by checking ease of laryngoscopy, vocal cord view/opening, limb movement and coughing during the procedure.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Modified Time Principle Induction (MTPI) with rocuroniumExperimental Treatment1 Intervention
Group II: RSI with succinylcholineActive Control1 Intervention

Rocuronium is already approved in United States, European Union, Canada, Japan for the following indications:

🇺🇸
Approved in United States as Zemuron for:
  • Endotracheal intubation
  • Mechanical ventilation
  • Surgical procedures requiring neuromuscular blockade
🇪🇺
Approved in European Union as Esmeron for:
  • Endotracheal intubation
  • Mechanical ventilation
  • Surgical procedures requiring neuromuscular blockade
🇨🇦
Approved in Canada as Esmeron for:
  • Endotracheal intubation
  • Mechanical ventilation
  • Surgical procedures requiring neuromuscular blockade
🇯🇵
Approved in Japan as Esmeron for:
  • Endotracheal intubation
  • Mechanical ventilation
  • Surgical procedures requiring neuromuscular blockade

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Health Science Center, Houston

Lead Sponsor

Trials
974
Recruited
361,000+

Findings from Research

In a study of 1,045 patients requiring intubation during air medical transport, succinylcholine was found to significantly improve the odds of successful first-attempt intubation compared to rocuronium, with an odds ratio of 1.4.
Patients receiving succinylcholine also required fewer attempts to achieve intubation, with an odds ratio of 1.5, indicating that succinylcholine may be a more effective choice for rapid-sequence intubation in emergency settings.
Rocuronium versus succinylcholine in air medical rapid-sequence intubation.Hiestand, B., Cudnik, MT., Thomson, D., et al.[2022]
Rocuronium, at doses of 0.9-1.2 mg/kg, has a rapid onset time for tracheal intubation that is comparable to succinylcholine (50-75 seconds), making it a viable alternative for rapid-sequence induction of anesthesia.
Unlike succinylcholine, rocuronium has a longer clinical duration of action, which may provide additional benefits in certain clinical situations, while also avoiding the adverse reactions associated with succinylcholine.
Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients.Magorian, T., Flannery, KB., Miller, RD.[2022]
In a study involving 240 women undergoing cesarean delivery, rocuronium with sugammadex was found to be noninferior to succinylcholine in terms of time to tracheal intubation, with only a 2.9-second longer average time.
Rocuronium also resulted in fewer complications, such as postpartum myalgia and subjective complaints, compared to succinylcholine, indicating it may be a safer alternative for rapid-sequence induction in this setting.
Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.Stourac, P., Adamus, M., Seidlova, D., et al.[2018]

References

Rocuronium versus succinylcholine in air medical rapid-sequence intubation. [2022]
Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients. [2022]
Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation. [2018]
A comparison of succinylcholine and rocuronium for rapid-sequence intubation of emergency department patients. [2019]
Succinylcholine Is Associated with Increased Mortality When Used for Rapid Sequence Intubation of Severely Brain Injured Patients in the Emergency Department. [2018]
Determination of dose and efficacy of atracurium for rapid sequence induction of anesthesia: A randomised prospective study. [2022]
Effect of Rocuronium vs Succinylcholine on Endotracheal Intubation Success Rate Among Patients Undergoing Out-of-Hospital Rapid Sequence Intubation: A Randomized Clinical Trial. [2020]
Emergency department use of neuromuscular blocking agents in children. [2019]
Effect of paralytic type on time to post-intubation sedative use in the emergency department. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security